Here's Why Moderna Stock Rose as Much as 10.8% Today
Shares of Moderna (NASDAQ: MRNA) rose nearly 11% today after the company confirmed to CNBC that it's developing a vaccine for the coronavirus emanating from China. Public health officials in China have reported hundreds of cases and at least nine deaths, while other countries, including the United States, have confirmed at least one case in the last week.
According to an SEC filing describing its disclosure to CNBC, Moderna is working with American health institutions including the National Institute of Health (NIH) to develop the vaccine. As of 11:23 a.m. EST, the pharma stock had settled to a 5.8% gain.
Image source: Getty Images.
Source Fool.com
